Vineet N. KewalRamani, Ph.D.Link to KewalRamani home pageLink to KewalRamani research pageLink to KewalRamani publications pageLink to KewalRamani staff page
... Skip navigation links
Link to home page of HIV Drug Resistance Program website
Link to Mission, HIV Drug Resistance Program, National Cancer Institute
Link to News & Events, HIV Drug Resistance Program, National Cancer Institute
Link to Research Team, HIV Drug Resistance Program, National Cancer Institute
Link to Clinical Trials, HIV Drug Resistance Program, National Cancer Institute
Link to Recruitment, HIV Drug Resistance Program, National Cancer Institute
Link to Resources, HIV Drug Resistance Program, National Cancer Institute
Link to Related Sites, HIV Drug Resistance Program, National Cancer Institute
Link to Staff Directory, HIV Drug Resistance Program, National Cancer Institute

Link to National Cancer Institute - external website
Link to National Cancer Institute at Frederick - external website
...

Photo of Vineet N. KewalRamani

Head, Model Development Section

HIV Drug Resistance Program
Center for Cancer Research
National Cancer Institute
P.O. Box B, Building 535
Frederick, MD 21702-1201
Phone: 301-846-1249
Fax: 301-846-6777
E-mail: vineet@mail.nih.gov


Dr. Vineet N. KewalRamani first developed an interest in retroviruses as an undergraduate in the University of Wisconsin at Madison.  After choosing to pursue molecular biology as a career, he enrolled in the graduate program at the University of Washington in Seattle where he studied HIV molecular replication at the Fred Hutchinson Cancer Research Center.  Upon completing his Ph.D. training in 1996, he received a fellowship from the Damon Runyon Cancer Research Foundation and a postdoctoral position from New York University where he examined HIV infection within an immunological context.  While working in NYU, he joined in an effort to develop a mouse model for HIV replication using transgenic technologies.  These studies provided the foundation for his groupís current work at the National Cancer Institute.  Today, his team investigates the role of host factors in HIV infection and the biology of HIV in animal models.  HIV and other retroviruses hack the host organismís genetic program to propagate their code.  They also rapidly evolve in the face of selective pressure.  By illuminating how retroviruses co-opt host functions while evading antiviral drugs or immune responses, his lab seeks to develop new strategies to impede the dynamic viral program.

Dr. KewalRamani was the 2011 and 2012 chair of the National Institutes of Health (NIH) Earl Stadtman Virology Search Committee and a co-organizer of the Cold Spring Harbor Laboratory 37th annual meeting on Retroviruses held in May of 2012.  He is a past chair of the NIH Norman Salzman Virology Scientific Committee.  He has served on the editorial boards of Journal of Virology, PLoS ONE, Retrovirology, and Virology.  He was tenured by the NIH in 2010.




Last modified: 21 November 2013

...



HIV DRP Home
Mission | News & Events | Research Team | Clinical Trials | Recruitment | Resources
Related Sites | Staff Directory | NCI Home | NCI at Frederick | Site Map | Disclaimers & Policies | Contact Us

Accessibility | Viewing Files

National Cancer Institute logo     Health and Human Services logo National Institutes of Health logo Logo of USA.gov official web portal